trueAmendment No. 1000162361300016236132020-06-302020-06-30 UNITED STATES SECURITIES AND EXCHANGE...
Mylan to Release Second Quarter 2020 Financial Results on Aug. 6, 2020 PR Newswire HERTFORDSHIRE, England and...
Filed by Mylan N.V. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to...
Filed by Mylan N.V. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed...
Filed by Mylan N.V. Pursuant to Rule 425 under the Securities Act of 1933 and...
Viatris Reveals Branding to Reflect New Company's Transformative Strategy Announcement follows Mylan shareholder approval of Mylan's combination...
Mylan and Fujifilm Kyowa Kirin Biologics Announce U.S. FDA Approval of Hulio® (adalimumab-fkjp) PR...
Mylan Initiates Voluntary Nationwide Recall of One Lot of Daptomycin for Injection, Due to the Presence of...
Mylan Secures Regulatory Approval for Remdesivir Lyophilized Powder for Injection 100 mg/vial in India for...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ...
Filed by Mylan N.V. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6(b...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.